Sectors
ZBIO
Zenas BioPharma, Inc.
32.32
2 x 23.02
2 x 39.47
bid
ask
+
1.05
3.36%
2 @ 07:30 PM
32.32 +0.00 (0.00%)
| Ytd | -10.99% | |
| 1y | 102.00% |
29.88
day range
32.77
13.50
52 week range
44.60
| Open | 31.51 | Prev Close | 31.27 | Low | 29.88 | High | 32.77 | Mkt Cap | 2.11B |
| Vol | 527.68K | Avg Vol | 847.21K | EPS | -9.63 | P/E | N/A | Forward P/E | -6.94 |
| Beta | -1.03 | Short Ratio | 16.49 | Inst. Own | 93.15% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 29.47 | 200-d Avg | 26.06 | 1yr Est | 47.00 |
| Income Statement | |||
| Total Revenue | 1000.00K | ||
| Revenues (USD) | 1000.00K | ||
| Gross Profit | 1000.00K | ||
| Operating Expenses | 108.66M | ||
| Research and Development Expense | 62.91M | ||
| Selling, General and Administrative Expense | 15.75M | ||
| Operating Income | -107.66M | ||
| Interest Expense | 10.30M | ||
| Income Tax Expense | 114.00K | ||
| Net Income | -111.46M | ||
| Net Income Common Stock | -111.46M | ||
| Net Income Common Stock (USD) | -111.46M | ||
| Consolidated Income | -111.46M | ||
| Earnings per Basic Share | -1.77 | ||
| Earnings per Basic Share (USD) | -1.77 | ||
| Earnings per Diluted Share | -1.77 | ||
| Earning Before Interest & Taxes (EBIT) | -101.04M | ||
| Earning Before Interest & Taxes (USD) | -101.04M | ||
| Weighted Average Shares | 63.11M | ||
| Weighted Average Shares Diluted | 63.11M | ||
| Balance Sheet | |||
| Cash and Equivalents | 196.58M | ||
| Cash and Equivalents (USD) | 196.58M | ||
| Investments | 477.31M | ||
| Investments Current | 446.55M | ||
| Investments Non-Current | 30.76M | ||
| Current Assets | 653.79M | ||
| Property, Plant & Equipment Net | 844.00K | ||
| Total Assets | 701.69M | ||
| Debt Current | 823.00K | ||
| Total Debt | 297.86M | ||
| Current Liabilities | 65.82M | ||
| Debt Non-Current | 297.04M | ||
| Total Liabilities | 454.59M | ||
| Accumulated Retained Earnings (Deficit) | -957.57M | ||
| Accumulated Other Comprehensive Income | -1.14M | ||
| Shareholders Equity | 247.10M | ||
| Shareholders Equity (USD) | 247.10M | ||
| Assets Non-Current | 47.90M | ||
| Total Debt (USD) | 297.86M | ||
| Liabilities Non-Current | 388.78M | ||
| Trade and Non-Trade Payables | 7.59M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 273.00K | ||
| Net Cash Flow from Financing | 42.06M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -303.65M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -30.00M | ||
| Issuance (Purchase) of Equity Shares | 14.42M | ||
| Issuance (Repayment) of Debt Securities | 27.64M | ||
| Net Cash Flow from Investing | -287.70M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -257.70M | ||
| Net Cash Flow from Operations | -57.24M | ||
| Effect of Exchange Rate Changes on Cash | -763.00K | ||
| Share Based Compensation | 8.62M | ||